K22
K22 is an inhibitor of coronavirus RNA synthesis that specifically targets membrane-associated coronavirus RNA synthesis. K22 effectively blocks replication of multiple coronaviruses by inhibiting the critical step of viral replication complex anchoring to host cell membranes to form double-membrane vesicles (DMVs) . K22 exhibits broad-spectrum antiviral activity against diverse coronaviruses, including Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Feline Coronavirus (FCoV), Mouse Hepatitis Virus (MHV), and Avian Infectious Bronchitis Virus (IBV) [1].
Product Specifications
CAS Number
2141978-86-9
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Purity
98.46
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N/C(C(N1CCC(O)(C2=CC=C(Br)C=C2)CC1)=O)=C\C3=CC=CC=C3)C4=CC=CC=C4
Molecular Formula
C27H25BrN2O3
Molecular Weight
505.40
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) ELISA Kit
Human Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) ELISA Kit
Human Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) ELISA Kit
Human Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) ELISA Kit
Human Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) ELISA Kit
